Andrea Masi Selected Research

Infections

1/2016	Novel Clostridium difficile Anti-Toxin (TcdA and TcdB) Humanized Monoclonal Antibodies Demonstrate In Vitro Neutralization across a Broad Spectrum of Clinical Strains and In Vivo Potency in a Hamster Spore Challenge Model.
5/2003	A new percutaneous nephrostomy technique in the treatment of obstructive uropathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Masi Research Topics

Disease

2	Infections 01/2016 - 05/2003
1	Breast Neoplasms (Breast Cancer) 04/2005
1	Cysts 11/2004
1	Sepsis (Septicemia) 05/2003

Drug/Important Bio-Agent (IBA)

1	Humanized Monoclonal AntibodiesIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	trimethylaminocarboxyldihydroboran (TCDB)IBA 01/2016
1	Sclerosing Solutions (Sclerosing Agents)IBA 11/2004
1	Polidocanol (Laureth)FDA Link 11/2004
1	A 7 (A-7)IBA 11/2004

Therapy/Procedure

2	Catheters 11/2004 - 05/2003
1	Segmental Mastectomy (Lumpectomy) 04/2005
1	Surgical Instruments (Clip) 11/2004
1	Therapeutics 11/2004
1	Sclerotherapy 11/2004
1	Nephrotomy 05/2003